Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New test for most virulent HPV strains under study

21.02.2007
A test for the two strains of human papillomavirus responsible for most cervical cancers is under study.

The molecular assay uses a cervical scraping, like that for a liquid-based Pap smear, to test for HPV types 16 and 18, responsible for 70 percent of cervical cancers, says Dr. Daron G. Ferris, family medicine physician and director of the Gynecologic Cancer Prevention Center at the Medical College of Georgia.

“Data from a National Cancer Institute trial shows that if you have a genital infection with HPV types 16 or 18, your chance of getting moderate to severe precancerous cervical changes or cancer is much higher than if you have one of the other types,” says Dr. Ferris, a principal investigator on the national study evaluating the assay.

The NCI study followed women infected with different types of the typically slow-acting virus over 10 years. It found women infected with type 18 had a 15 percent risk of cancerous or pre-cancerous changes after 10 years, those with type 16 had a 20 percent increased risk while those with the 11 other strains had a collective risk of 1-2 percent.

“Clearly, there is a big difference between HPV types 16 and 18 and all the other cancer-causing strains of HPV,” says Dr. Ferris.

The type-specific assay, developed by Third Wave Technologies, Inc., in Madison, Wis., is being tested along with an assay that looks for the presence of 14 types of cancer-causing HPV. A test that detects 13 types of HPV already is commercially available, so the new test could become the second non-type-specific HPV test on the market.

Dr. Ferris, who was involved in early studies of the HPV vaccines, hopes the new tests will one day provide better options for screening for the most common sexually transmitted disease.

The current national study is giving the new HPV test and the type-specific assay to 1,500 women age 30 and older with a negative Pap test and to 1,000 women age 18 and older with cervical cell changes of undetermined significance – pathologists call this most common abnormal result ASC-US – or higher-grade abnormalities.

“These are the two ways to use HPV testing,” says Dr. Ferris. “One is as a primary screening adjunct test with a Pap test for women age 30 and older and the other is as a triage test when women have an abnormal Pap smear result.”

An HPV test typically follows an ASC-US Pap smear which at best, is about 80 percent accurate, he says.

However, the HPV test, which is more accurate, has not become widely accepted as a primary screening tool for women age 30 and older, he says, citing cost and the tradition of Pap smears as likely factors.

“This new HPV test could lengthen the interval of screening for cervical cancer. If the new test is as good as the old one and if the HPV test is negative, there is only a 1 percent chance you actually have something wrong,” he says, noting that Pap smears really don’t add much to the equation.

Still, when he lectures around the country and asks for a show of hands of physicians using HPV tests in women over 30, few go up; he hopes that will change.

“I think it’s a possibility in the future that we won’t be doing Pap smears on women over 30; it might just be screening with an HPV test. A lot of experts are suggesting maybe that is the way we should go,” he says.

In fact, the American College of Obstetricians and Gynecologists and American Society for Colposcopy and Cervical Pathology already recommend HPV testing in all women over 30.

Women under 30 are another matter. Ages 15 to 25 are peak sexual activity years and peak years for HPV infection, says Dr. Ferris. Fortunately, the vast majority of the infections are cleared; ones that persist to age 40 are most likely to cause problems. “Seventy percent of patients clear the infection. The 30 percent who don’t, if they still have it by the time they are age 40, are heading down the wrong path,” he says. Less expensive Pap smears likely would continue to be used in the under-30 group to catch the few infections that become problematic in this age group.

Currently, there are not FDA-approved drugs to cure cervical pre-cancers and cancers caused by HPV, although centers such as MCG are evaluating potential therapies. Resulting cervical changes may be followed with frequent Pap smears or colposcopy, in which physicians can view the cervix and freeze, excise or vaporize significant cellular changes.

For more information about the study, call Study Coordinator Ansley Dennis in Dr. Ferris’ office at 706-721-2535.

Toni Baker | EurekAlert!
Further information:
http://www.mcg.edu

More articles from Studies and Analyses:

nachricht A sudden drop in outdoor temperature increases the risk of respiratory infections
11.01.2017 | University of Gothenburg

nachricht Urbanization to convert 300,000 km2 of prime croplands
27.12.2016 | Mercator Research Institute on Global Commons and Climate Change (MCC) gGmbH

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>